Clinical trials
Connective Tissue Diseases trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 2 |
| United Therapeutics | 2 |
| AbbVie | 1 |
| Azienda Unita Sanitaria Locale di Piacenza | 1 |
| Biogen | 1 |
| Eli Lilly and Company | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| GlaxoSmithKline | 1 |
| Società Italiana di Allergologia, Asma e Immunologia Clinica | 1 |
| Sumitomo Pharma Switzerland GmbH | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Connective Tissue Diseases | 13 |
| Lupus Erythematosus, Systemic | 5 |
| Autoimmune Diseases | 4 |
| Lung Diseases, Interstitial | 4 |
| Arthritis, Rheumatoid | 3 |
| Immune System Diseases | 3 |
| Lung Diseases | 3 |
| Cardiovascular Diseases | 2 |
| Familial Primary Pulmonary Hypertension | 2 |
| Hypertension | 2 |
Trials
Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.